Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02237170
What this trial is testing

Immune Monitoring on Sipuleucel-T

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 36
Testing effectiveness (Phase 2)Study completedNCT01683994
What this trial is testing

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Ended earlyNCT05501548
What this trial is testing

Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Large-scale testing (Phase 3)Study completedNCT00003343
What this trial is testing

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 525
Testing effectiveness (Phase 2)Study completedNCT01812746
What this trial is testing

Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
CRPCProstate Cancer
BIND Therapeutics 42
Not applicableStudy completedNCT01160705
What this trial is testing

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Who this might be right for
Metastatic CancerProstate Cancer
Cancer Trials Ireland 73
Testing effectiveness (Phase 2)Study completedNCT03101046
What this trial is testing

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

Who this might be right for
Prostate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more
UNICANCER 40
Testing effectiveness (Phase 2)Ended earlyNCT05917470
What this trial is testing

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Oncternal Therapeutics, Inc 21
Early research (Phase 1)Study completedNCT00415779
What this trial is testing

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute, Naples 36
Testing effectiveness (Phase 2)Study completedNCT00046826
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

Who this might be right for
Prostate Cancer
Nuvance Health
Early research (Phase 1)Study completedNCT01186484
What this trial is testing

Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Pharmaceutical K.K. 27
Testing effectiveness (Phase 2)Study completedNCT02346526
What this trial is testing

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Testing effectiveness (Phase 2)Study completedNCT00514267
What this trial is testing

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Who this might be right for
Prostate CancerTumors
Astellas Pharma Inc 32
Large-scale testing (Phase 3)Active Not RecruitingNCT03574571
What this trial is testing

Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 732
Testing effectiveness (Phase 2)WithdrawnNCT02793765
What this trial is testing

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT00116155
What this trial is testing

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys
Testing effectiveness (Phase 2)Ended earlyNCT00953576
What this trial is testing

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT02928432
What this trial is testing

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 26
Testing effectiveness (Phase 2)Looking for participantsNCT06249750
What this trial is testing

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (CRPC)
Pengyuan Liu 60
Next Page